Lastly, MeCP2 has been shown to bind to methyltransferase-like 14 (METTL14), thereby promoting CRC metastasis and progression through the modulation of the tumor suppressor Krüppel-like factor 4 (KLF4) via m6A methylation core modification [45]. The gene discussed is KLF4; the disease is colorectal carcinoma.